Phase I trial of HTL-0022562 in healthy volunteers for the treatment of migraine

Trial Profile

Phase I trial of HTL-0022562 in healthy volunteers for the treatment of migraine

Planning
Phase of Trial: Phase I

Latest Information Update: 19 Mar 2018

At a glance

  • Drugs HTL 0022562 (Primary)
  • Indications Migraine
  • Focus Adverse reactions
  • Sponsors Sosei
  • Most Recent Events

    • 19 Mar 2018 New trial record
    • 13 Mar 2018 According to a Sosei media release, earlier the first dosing in the Phase I clinical trial in healthy volunteers was expected in late 2018. Sosei will provide an update about the trial later this year
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top